RAPH — Raphael Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Raphael Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.63 | -3.36 | -1.34 | -1.52 | -1.28 |
| Depreciation | |||||
| Non-Cash Items | — | 2.29 | 0.2 | 0.39 | 0.245 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.206 | 0.309 | -0.059 | 0.597 | 0.824 |
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.42 | -0.759 | -1.2 | -0.532 | -0.21 |
| Capital Expenditures | — | -0.002 | — | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | -0.002 | — | — | — |
| Financing Cash Flow Items | 0.013 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.48 | 0.896 | 1.15 | 0.321 | 0.236 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.058 | 0.135 | -0.058 | -0.211 | 0.026 |